Science & Enterprise subscription

Follow us on Twitter

  • The data show in major American and European cities, as well as Wuhan, China, the percentage of the population with… https://t.co/kXBqtTLwqp
    about 35 mins ago
  • New post on Science and Enterprise: Infographic – Major Cities Far Short of Herd Immunity https://t.co/ijj1IqTb6V #Science #Business
    about 38 mins ago
  • An evaluation of a two year-old home care service for cancer patients shows the program reduces chances of later ho… https://t.co/TupWwuG3ok
    about 19 hours ago
  • New post on Science and Enterprise: Home-Based Cancer Care Boosts Outcomes, Cuts Costs https://t.co/9zcrG432As #Science #Business
    about 19 hours ago
  • Trump: U.S. will terminate relationship with the World Health Organization in wake of Covid-19...… https://t.co/nUXjHixhfe
    about 20 hours ago

Please share Science & Enterprise

Health Research Commercialization Company Launched

Microscope

University of Michigan and health care investor Deerfield Management are creating a new enterprise to bring promising academic life science research to market. . . . → Read More: Health Research Commercialization Company Launched

Merck Inks Three Covid-19 Vaccine, Therapy Deals

SARS-Cov-2 virus

Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections. . . . → Read More: Merck Inks Three Covid-19 Vaccine, Therapy Deals

GSK, Biotech Partner on Crispr Covid-19 Test

Crispr genome edits illustration

A biotechnology company using gene editing for diagnostics is developing a fast, point-of-care Covid-19 test with drug maker GlaxoSmithKline. . . . → Read More: GSK, Biotech Partner on Crispr Covid-19 Test

Venture Producing Covid-19 Antibody Test Kits

SARS-Cov-2 virus

A new company formed from a medical research lab is producing test kits for detecting and measuring a person’s Covid-19 antibodies. . . . → Read More: Venture Producing Covid-19 Antibody Test Kits

FDA Analyzing Real-World Evidence on Covid-19

Network pointer

The Food and Drug Administration is analyzing collections of health records to gain more evidence-based insights into the course of the Covid-19 pandemic. . . . → Read More: FDA Analyzing Real-World Evidence on Covid-19

FDA Stops Home Covid-19 Diagnostic Test

Covid-19 illustration

The Food and Drug Administration asked designers of a Covid-19 test collecting samples at home for research to stop giving results to individuals. . . . → Read More: FDA Stops Home Covid-19 Diagnostic Test

Covid-19 Lung Disease Trial Adds Treatments

Inspecting lung X-rays

A clinical trial testing treatments for lung damage in severe Covid-19 cases is adding the anti-viral drug remdesivir and convalescent plasma to its protocol. . . . → Read More: Covid-19 Lung Disease Trial Adds Treatments

FDA Issues Covid-19 Therapy Trials, Review Guidance

Syringes

The Food and Drug Administration issued new regulatory guidance on clinical trials and streamlined review processes for Covid-19 treatments. . . . → Read More: FDA Issues Covid-19 Therapy Trials, Review Guidance

Stem Cell Therapy Licensed for Genetic Eye Disease

Red-blue-green eye

A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million. . . . → Read More: Stem Cell Therapy Licensed for Genetic Eye Disease

Biotech Gains Antibody Discovery, Manufacturing Funds

Global Covid-19

A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics. . . . → Read More: Biotech Gains Antibody Discovery, Manufacturing Funds